Posts in category Business Standard
Zydus launches Mirabegron ER Tablets in US market (22-04-2024)
Zydus Lifesciences announced the launch of Mirabegron Extended-Release Tablets, 25 mg in the US market. The company had earlier received final approval from the United States Food and Drug Administration (USFDA) to market Mirabegron Extended-Release Tablets USP 25 mg and 50 mg (USRLD: Myrbetriq Extended-Release Tablets). Zydus is among the first suppliers to launch the generic version of Mirabegron Extended-Release Tablets, USP 25 mg in the US market and is prepared to launch Mirabegron Extended-Release Tablets, 50mg imminently.
HDFC Bank, Wipro, Jio Financial, UltraTech Cement in focus (22-04-2024)
HDFC Bank: The bank said that its net profit jumped 37.06% to Rs 16,511.85 crore in Q4 FY24 as compared with Rs 12,047.45 crore posted in Q4 FY23. Total income jumped 66.46% YoY to Rs 89,6939 crore as compared with Rs 53,850.54 crore posted in corresponding quarter last year.
Persistent Systems consolidated net profit rises 25.37% in the March 2024 quarter (22-04-2024)
Sales rise 14.91% to Rs 2590.53 crore
Firm opening on the cards (22-04-2024)
GIFT Nifty:
India’s Forex Reserves Decline $5.40 Billion To $643.16 Billion (22-04-2024)
For the week ended April 12, the foreign currency assets, a major component of the reserves, decreased by $6.513 billion to $564.653 billion, according to the data released on April 19.
Indian forex, bond investors eye developments in Middle East, US inflation (22-04-2024)
The currency fell 0.1 per cent in the week to end at 83.47, and the losses would have been larger had it not been for the Reserve Bank of India's (RBI) intervention
Provisional Net Direct Tax Collections For FY24 Exceed Budget Estimates By By 7.40% (22-04-2024)
The Budget Estimates (BE) for Direct Tax revenue in the Union Budget for FY 2023- 24 were fixed at Rs. 18.23 lakh crore which were revised and the Revised Estimates (RE) were fixed at Rs. 19.45 lakh crore. The provisional Direct Tax collections (net of the refunds) have exceeded the BE by 7.40% and RE by 0.67%.
5 things to know before the market opens on Monday; Gift Nifty hints gap-up (22-04-2024)
Stock market preview April 22: HDFC Bank stock will react to Q4 results, Reliance eyed; global cues and FII flows are among key factors that will determine the market trajectory on Monday.
Lupin Launches Mirabegron tablets (22-04-2024)
Lupin on Saturday announced that it has received an approval from US Food and Drug Administration (USFDA) for the launch of Mirabegron extended-release tablets, 25 mg, in the United States.